New lung treatment aims to zap hidden cancer cells during surgery
NCT ID NCT02811523
Summary
This early-stage study is testing a new technique called In Vivo Lung Perfusion (IVLP) for people with bone or soft tissue sarcoma that has spread to both lungs. During surgery to remove visible tumors, doctors will deliver chemotherapy directly to one lung for 3 hours to try to kill microscopic cancer cells that can't be seen, while sparing the rest of the body from chemo side effects. The main goal is to see if this approach is safe and to find the right dose, with patients being followed for up to 2 years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.